ClinicalTrials.Veeva

Menu

Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors

Samsung Medical Center logo

Samsung Medical Center

Status

Enrolling

Conditions

Lung Cancer
Lung Neoplasm

Treatments

Other: Comprehensive care program
Other: Usual care

Study type

Interventional

Funder types

Other

Identifiers

NCT05078918
SMC 2021-08-071

Details and patient eligibility

About

The purpose of this study is to develop a comprehensive care program for their return to normal life and community among lung cancer survivors and evaluate the effectiveness of the program.

Full description

Lung cancer patients scheduled for curative surgery will be enrolled in this study. The comprehensive care program will be developed, and provided to the intervention group before and after surgery. Outcomes will be assessed 6 months and 1 year after surgery. To evaluate the effectiveness of the program, a control group will be enrolled first and used as a comparator.

Enrollment

800 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with non-small cell lung cancer(NSCLC) and scheduled for curative resection.
  • NSCLC with clinical stage Ⅰ-Ⅲ
  • Patients who understood the study and gave written informed consent.

Exclusion criteria

  • Recurred lung cancer
  • Patients with extra-pulmonary synchronous double primary cancer.
  • Patients with history of other cancer diagnosis or treatment in the last 3 years.

Drop Criteria:

  • When surgery was canceled or pathologic stage IV was confirmed after surgery.
  • When the tumor was not found to be non-small cell lung cancer, including benign tumor, after surgery
  • Withdrawal informed consent.

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

800 participants in 2 patient groups

Comprehensive care program
Experimental group
Description:
Intervention group receiving newly developed comprehensive care program pre- and post-operatively.
Treatment:
Other: Comprehensive care program
Usual care
Active Comparator group
Description:
Control group receiving usual care
Treatment:
Other: Usual care

Trial contacts and locations

1

Loading...

Central trial contact

Genehee Lee, APN., M.S.N.; Dong Wook Shin, MD., Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems